Streptococcus pneumoniae capsular polysaccharide serotype 23F (Pneumococcal polysaccharide 23F; CPS23F)

The capsular polysaccharide of Streptococcus pneumoniae serotype 23F is a repeating tetrasaccharide unit that forms the outermost surface layer of this clinically important human pathogen. This polysaccharide serves as a major virulence factor by protecting the bacterium from phagocytic killing through inhibition of complement deposition, opsonization, and neutrophil-mediated clearance mechanisms. Serotype 23F is one of the high-prevalence serotypes, with its specific polysaccharide structure conferring enhanced resistance to immune attack and enabling prolonged nasopharyngeal carriage. The polysaccharide is the primary target of pneumococcal vaccines (such as PPSV23), which elicit serotype-specific antibody responses; however, protection is strictly serotype-specific, and there are 98 recognized serotypes, limiting vaccine coverage. The biochemical structure of the capsular polysaccharide—including factors such as monosaccharide composition and hydrophobic residue content—directly influences the degree of encapsulation and the serotype's epidemiological success in human populations, making it both a critical virulence determinant and an important vaccine target.

Other names

Pneumococcal capsular polysaccharide type 23FPolysaccharide capsule of Streptococcus pneumoniae serotype 23FAmerican type 23

The capsular polysaccharide employs multiple mechanisms to evade immunity: Inhibits both classic and alternative complement pathways by limiting binding of immunoglobulins, complement components, and C-reactive protein to deeper bacterial surface structures. Reduces opsonization with C3b/iC3b and physically impairs interactions between bound complement or antibody Fc regions with receptors on phagocytic cells. Inhibits entrapment of pneumococci in neutrophil extracellular traps. Impedes recognition of Toll-like receptor ligands on the bacterial surface.